NUVL
NUVL
GSK to acquire Nuvalent in merger agreement dated June 9, 2026
GlaxoSmithKline LLC agreed to acquire Nuvalent, Inc. through a merger with subsidiary Harmony Row Acquisition Co., with terms outlined in an executed agreement and plan of merger. The transaction represents a significant consolidation in the pharmaceutical sector, combining GSK's established operati…
BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.